Company intelligence / Profile preview

Xiang He Capital

Palo Alto, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Xiang He Capital is a China-focused venture capital fund investing in early and growth-stage technology companies (AI, advanced manufacturing, new energy, new materials, automotive, enterprise services, TMT), including some healthcare- and life-science-adjacent technology plays, but it is not itself a biotech or healthcare company.[1][2][3][4]

Industry: Investors

Beyond the preview

Go deeper on Xiang He Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiang He Capital.

Explore the full profile